Serum amyloid A - An indicator of inflammation in ankylosing spondylitis

Rheumatology International

Volumn 19, Issue 4, 2000, Pages 119-122

  Lange, U ^a   Boss, B ^a   Teichmann, J ^a   Klor H U ^a   Neeck, G ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Ankylosing spondylitis; Disease activity; Serum amyloid A

Indexed keywords

AMYLOID A PROTEIN; C REACTIVE PROTEIN; MARKER; SERUM AMYLOID A;

ADULT; AMYLOIDOSIS; ANKYLOSING SPONDYLITIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE ACTIVITY; DISEASE PREDISPOSITION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; INFLAMMATION; MALE; PATIENT MONITORING; PRIORITY JOURNAL; SCORING SYSTEM;

ADULT; APOLIPOPROTEINS; BIOLOGICAL MARKERS; FEMALE; HUMANS; INFLAMMATION; MALE; SERUM AMYLOID A PROTEIN; SPONDYLITIS, ANKYLOSING;

EID: 0034104311     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002960050114     Document Type: Article

References (30)

1. 1. Aldo-Benson MA, Benson MD (1982) SAA suppression of immune response in vitro: evidence for an effect on T cell-macrophage interaction. J Immunol 126: 2390-2392
2. 2. Benson M, Cohen A (1979) Serum Amyloid A protein in amyloidosis, rheumatic and neoplastic diseases. Arthritis Rheum 22: 36-42
3. 3. Betts JC, Edbrooke MR, Thakker RV, Woo P (1991) The human acute-phase serum amyloid. A gene family: structure, evolution and expression in hepatoma cells. Scand J Immunol 34: 471-482
4. 4. Blackburn WD Jr (1994) Validity of acute phase proteins as markers of disease activity. J Rheumator Suppl 42: 9-13
5. 5. Chambers RE, Stross P, Barry PE, Whicher JT (1987) Serum amyloid A protein compared with C-reactive protein, alpha 1-antichymotrypsin and alpha 1-acid glycoprotein as a monitor of inflammatory bowel disease. Eur J Clin Invest 17: 460-467
6. 6. Chambers RE, Hutton CW, Dieppe PA, Whicher TJ (1991) Comparative study of C-reactive protein and serum amyloid A protein in experimental inflammation. Ann Rheum Dis 50: 677-679
7. 7. Duff GW (1994) Cytokines and acute phase proteins in rheumatoid arthritis. Scand J Rhenumatol Suppl 100: 9-19
8. 8. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisfrod P, Callin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21: 2286-2291
9. 9. Glomset JA (1968) The plasma lecithins: cholesterol acyltransferase reaction. J Lipid Res 9: 155-167
10. 10. Hilliquin P (1995) Biological markers in inflammatory rheumatic diseases. Cell Mol Biol (Noisy-le-grand) 41: 993-1006
11. 11. Husby G, Natvig JB (1974) A serum component related to nonimmunoglobulin amyloid protein AS, a possible precursor of the fibrils. J Clin Invest 53: 1054-1061
12. 12. Kisilevsky R (1991) Serum amyloid A (SAA), a protein without a function: some suggestions with reference to cholesterol metabolism. Med Hypotheses 35: 337-341
13. 13. Kushner I (1982) The phenomenon of the acute phase response. In C-reactive protein and the plasma protein response to tissue injury, Ann NY Acad Sci 389: 39-48
14. 14. Kushner I, Rzewnicki DL (1994) The acute phase response-general aspects. Baillieres Clin Rheumatol 8: 513-530
15. 15. Levin M, Pars M, Franklin EC (1973) Immunologic studies of the major nonimmunoglobulin protein of the amyloid. I. Identification and partial characterization of a related serum component. J Exp Med 138: 373-380
16. 16. Marhaug G, Dowton SB (1994) Serum amyloid A: an acute phase apolipoprotein and precursor of AA amyloid. Baillieres Clin Rheumatol 3: 553-573
17. 17. Markinovic S, Jahreis GP, Wong GG, Baumann H (1989) IL-6 modulates the synthesis of a specific set of acute phase proteins in vivo. J Immunol 142: 802-812
18. 18. Migita K, Eguchi K, Tsukada T, Kawabe Y, Takashima H, Mine M, Aoyagi T, Ichinose Y, Nagataki S (1996) Increased circulating serum amyloid A protein derivates in rheumatoid arthritis patients with secondary amyloidosis. Lab Invest 75: 371-375
19. 19. Moll JMH, Wright V (1973) New York clinical criteria for ankylosing spondylitis: a statistical evaluation. Ann Rheum Dis 32: 354-363
20. 20. Parmelee DC, Titani, K, Ericsson LH et al (1982) Amino acid sequence of amyloid-related apoprotein (apoSAA1) from human high-density lipoprotein. Biochemistry 21: 3298-3303
21. 21. Perlmutter DH, Dinarello CA, Punsal PI, Colten HR (1986) Cachectin/tumor necrosis factor regulates hepatic acute phase gene expression. J Clin Invest 78: 1349-1354
22. 22. Ramadori G, Sipe JD, Dinarello CA et al (1985) Pretranslational modulation of acute phase hepatic protein synthesis by murine recombinant interleukin 1 (IL-1) and purified human IL-1. J Exp Med 162: 930-942
23. 23. Reinhart WH (1988) Die Blutsenkung - ein einfacher und nützlicher Test? Schweiz Med Wochenschr 118: 839-844
24. 24. Schultz DR, Arnold PI (1990) Properties of four acute phase proteins: C-reactive protein, serum amyloid A protein, α1-acid glycoprotein, and fibrinogen. Semin Arthritis Rheum 20: 129-147
25. 25. Sipe JD (1995) Acute-phase proteins in osteoarthritis. Semin Arthritis Rheum 25: 75-86
26. 26. Sletten K, Marhaug G, Husby G (1983) The covalent structure of amyloid-related serum protein SAA from two patients with inflammatory disease. Hoppe-Seylers Zeitschr Physiol Chem 364: 1039-1046
27. 27. Sukenik S, Henkin J, Zimlichman S et al (1988) Serum and synovial fluid levels of serum amyloid A protein and C-reactive protein in inflammatory and non-inflammatory arthritis. J Rheumatol 15: 942-945
28. 28. Syversen PV, Sletten K, Husby G (1990) Evolutionary aspects of protein SAA. In: Natvig JB, Forre O, Husby et al (eds) Amyloid and amyloidosis. Kluwer, Dordrecht, pp 111-114
29. 29. van Rijswijk MH (1981) Amyloidosis. Phd thesis, University of Groningen, The Netherlands
30. 30. Wolfe F (1997) Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis. J Rheumatol 24: 1477-1485